A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors

Overview of attention for article published in BMC Medical Genomics, June 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

patent: 7 patents

Citations

dimensions_citation: 128 Dimensions

Readers on

mendeley: 174 Mendeley
citeulike: 1 CiteULike
connotea: 1 Connotea

Summary Patents Dimensions citations

So far, Altmetric has seen 7 patents that reference this research output.

INHIBITORS OF KRAS G12C

Application EA-033689-B9

Eurasian Patent Organisation

INHIBITORS OF KRAS G12C

Application EP-3636639-A1

European Patent Office

INHIBITORS OF KRAS G12C

Application EA-033689-B1

Eurasian Patent Organisation

Selective inhibitors of tumor-initiating cells

Grant US-10435756-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.